RNA M6a-Regulated Circ-Znf609 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating FTO

Pujiao Yu,Jiaqi Wang,Gui-e Xu,Xuan Zhao,Xinxin Cui,Jingyi Feng,Jiangpeng Sun,Tianhui Wang,Michail Spanos,Helge Immo Lehmann,Guoping Li,Jiahong Xu,Lijun Wang,Junjie Xiao

DOI: https://doi.org/10.1016/j.jacbts.2022.12.005

IF: 9.531

2023-01-01

JACC Basic to Translational Science

Abstract:Cardiac death is a major burden for cancer survivors, yet there is currently no effective treatment for doxorubicin (DOX)-induced cardiotoxicity. Here, we report that circ-ZNF609 knockdown knockdown had cardioprotective effects against DOX-induced cardiomyocyte toxicity. Mechanistically, circ-ZNF609 knockdown alleviated DOX-induced cardiotoxicity through attenuating cardiomyocyte apoptosis, reducing reactive oxygen species production, ameliorating mitochondrial nonheme iron overload. circ-ZNF609 inhibition blocked the elevation of RNA N6-methyladenosine (RNA m6A) methylation level in DOX-treated mice hearts, whereas m6A demethylase fat mass and obesity associated (FTO) acted as the downstream factor of circ-ZNF609. Moreover, the stability of circ-ZNF609 was regulated by RNA m6A methylation alteration, and suppression of RNA m6A methylation by methyltransferase like 14 (METTL14) modulated the function of circ-ZNF609. These data suggest that circ-ZNF609 inhibition represents a potential therapy for DOX-induced cardiotoxicity.